|
Dictionary |
|
Lxh254 |
L-alanine 2-ethylbutyl ester hydrochloride |
L-phenylalanine, 2,4-dichloro-, ethyl ester |
L-phenylalanine, 4-bromo-, ethyl ester |
Lesinurad sodium |
Lithium trihydroxy(pyridin-2-yl)borate |
Lead silicate |
Lithium 2-hydroxy-4,4,5,5-tetramethyl-2-(1-methyl-1h-pyrazol-4-yl)-1,3,2-dioxaborolan-2 |
L-glutamic acid 5-tert-butyl 1-methyl ester |
L-glutamic acid, n-(1-oxohexadecyl)-, 1-methyl ester |
L-glutamic acid, n-(1-oxohexadecyl)-, 5-(1,1-dimethylethyl) 1-methyl ester |
Marcasite |
Lividomycin A Sulfate |
Ly117018 |
L-GLUTATHIONE OXIDISED |
L-tyrosine ethyl ester hydrochloride |
L-lysine, n6-(1-oxotetradecyl)-n2-[(phenylmethoxy)carbonyl]- |
L-tryptophan, n-[(9h-fluoren-9-ylmethoxy) carbonyl]-2-methyl- |
L-phenylalanine, 4-azido-, hydrochloride (1:1) |
Larotrectinib |
L-gluconamide, n-octyl- |
Lactonamycin |
Lincosamine |
Lipid x |
2-(L-rhamno-tetrahydroxypentyl)-4(r)-1,3-thiazolidine-4-carboxylic acid |
Lacto-n-difucohexaose i |
Lactodifucotetraose |
Lauryl maltose neopentyl glycol |
L-tyr-3-cyano-oh |
Linagliptin impurity i |
Linagliptin impurity k |
Linagliptin impurity p |
Linagliptin impurity s |
Linagliptin impurity t |
Luteolin 7-o-neohesperidoside |
L-tyrosine,o-2-propenyl-, hydrochloride(9ci) |
L-酪氨酸异丙酯盐酸盐 |
Lumbokinase capsules |
L-glutamic acid, n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-,1,5-dimethyl ester,4-methylbenzenesulfonate(1:1) |
L-asp-oet |
L-alanine, n-phenyl- |
L-alanine, n-[(9h-fluoren-9-ylmethoxy)carbonyl]-3-[[(2-nitrophenyl)sulfonyl]amino]- |
L-lysine, n2-[(1,1-dimethylethoxy)carbonyl]-n2-methyl-n6-[(phenylmethoxy)carbonyl]- |
L-lysine, n6-(2-hydroxy-2-methyl-1-oxopropyl)- |
L-lysine, n2-[(9h-fluoren-9-ylmethoxy)carbonyl]-n6-(1-oxobutyl)- |
L-lysine, n2-[(9h-fluoren-9-ylmethoxy)carbonyl]-n6-(2-hydroxy-2-methyl-1-oxopropyl)- |
Ly450108 |
Lithium(5-cyanopyridin-2-yl)trihydroxyborate |
L-valine, n-(3-cyanopropyl)- |
L-leucyl-l-phenylalaninemethylester |
|
|
|
Dictionary |
|
|
Product |
CAS |
Molecular formula |
More |
Linezolid dimer |
908143-04-4 |
C30H35F2N5O7 |
More |
Linezolid impurity (n,o-desethylene linezolid) |
1219708-30-1 |
C14H18FN3O4 |
More |
Lisinopril impurity e |
85955-59-5 |
C21H31N3O5 |
More |
Loxapine |
54810-23-0 |
C18H18ClN3O.ClH |
More |
Lorcaserin hcl hemihydrate |
856681-05-5 |
2(C11H14ClN).2(HCl).H2O |
More |
Loratadine ep impurity a |
133284-74-9 |
C22H25ClN2O3 |
More |
Loratadine ep impurity c |
165739-83-3 |
C22H22Cl2N2O2 |
More |
Loratadine-d5 |
1020719-57-6 |
|
More |
Loratadine ep impurity f |
125743-80-8 |
C22H23ClN2O2 |
More |
Losartan impurity k |
1159977-26-0 |
C21H20Cl2N6 |
More |
Losartan related compound a |
1247750-67-0 |
|
More |
Lercanidipine impurity b |
1119226-97-9 |
|
More |
Levonorgestrel impurity q |
1038-28-4 |
C20H30O2 |
More |
Levonorgestrel impurity t |
799-43-9 |
C22H30O2 |
More |
Levonorgestrel impurity n |
4222-96-2 |
C19H26O2 |
More |
Levofloxacin n-oxide |
117678-38-3 |
C18H20FN3O5 |
More |
Levofloxacin tetrafluoro impurity 2 |
103995-33-1 |
|
More |
Laropiprant-d4 |
1132664-22-2 |
|
More |
Levosimendan impurity (2-[2-[4-(2-azidotetrahydro-3-methyl-5-oxo-2-fur |
252638-01-0 |
C14H11N7O2 |
More |
Lipoic acid related compound |
916746-61-7 |
|
More |
|
|